
Alvotech (ALVO) via Oaktree Acquisition II (OACB) deck
Alvotech is a fully integrated specialty biopharmaceutical company focused on the development and manufacturing of high quality biosimilar medicines.
This post is for subscribers only
SubscribeAlready have an account? Log in